Opioid treatment receives $377m funding increase The measure, included in this week’s Federal Budget, will ‘save lives’, according to the RACGP President.
Drug ‘significantly’ slows Alzheimer’s progression: Study A clinical trial of donanemab has now been peer reviewed and published, indicating it can decelerate decline in the disease’s early stages.
Can doctor–patient differences have clinical implications? New research suggests doctors are more extroverted, but also more neurotic and less open than patients.
Program aims to ‘scale up’ hepatitis C testing GPs are being encouraged to sign up for Beyond the C, which is hoping to move Australia closer to eliminating the virus by 2030.
Codeine use down by 37% since up-scheduling Use of the drug has dropped substantially across all jurisdictions, a new wastewater-based epidemiology report suggests.
Review seeks to solve Better Access flaws Disparities in mental health access is a major theme of a comprehensive Government-commissioned evaluation of the 16-year-old initiative.
Physician, (do not) heal thyself SPONSORED: MDA National Senior Medical Adviser Dr Julian Walter discusses the limits of self-care and prescribing.
Concerns over growing misuse of Rikodeine cough medicine The addictive cough suppressant is popular among young people, more potent than codeine, and poses a serious risk of harm.
Concern over unproven menopause treatments Marketing has a lot to answer for but there is a role for general practice in educating women about choices, says GP Dr Karen Magraith.
Thousands expected to benefit from new PBS listings Medications for asthma, HIV, and Crohn’s disease have been added, while some heart, cholesterol and blood pressure drugs are now cheaper.